Table 3. Associations with anti-Hep-2 titers at initiation of therapy.

	High Titer anti-Hep-2 (>1:160)	Low Titer anti-HEP-2 (<1:160)	P
n	10	12	N/A
Age (years)	73 + 6	68 + 7	0.057
%Male	70	58	0.67
Antifibrotic Use	60	58	0.99
Supplemental O2 need >20L/min at therapy initiation	10	33	0.32